The Latest
-
Mobia Medical CEO eyes large market for stroke rehab
With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.
-
BD appoints Vitor Roque as permanent CFO
The company made Roque’s appointment permanent after considering external candidates for the role.
-
Tandem to file tubeless insulin pump with FDA this quarter
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.
-
Retrieved from Stryker Corporation on January 06, 2025
Stryker closes Amplitude Vascular acquisition
With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.
-
Roche to acquire digital pathology firm PathAI for up to $1.05B
Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.
-
Trade court rules Trump’s 10% global tariff illegal
Despite saying the levy was “unauthorized by law,” the U.S. Court of International Trade did not issue a universal stay.
Updated 13 hours ago -
FDA warns of neurosurgical supply disruptions
Interruptions in the supply of neurosurgical patties, sponges and strips are expected to continue through 2026.
-
Neptune Medical’s GI robot succeeds in colonoscopy study
The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.
-
Integra reappoints Stuart Essig as CEO
Essig filled the vacancy created when Mojdeh Poul and the Integra board mutually decided to end her time as CEO after less than 18 months.
-
Insulet raises revenue expectations for 2026
CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.
-
J&J’s Ottava robot meets goals in gastric bypass study
The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.
-
Retrieved from Viatris on May 05, 2026
Edwards names Theodora Mistras as CFO
Mistras, who joins the heart valve company after two years as CFO at pharmaceutical firm Viatris, also brings investment banking experience.
-
Olympus, EndoRobotics forge distribution pact
The deal to distribute EndoRobotics’ endoscopic robotic devices for gastroenterology follows Olympus’ agreement to co-launch Swan EndoSurgical, a startup developing a robotic GI platform.
-
Mobia Medical plans IPO
The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each.
-
Top medtech executive moves in 2026
Hologic, Teleflex, Grail and others are welcoming new CEOs, while STAAR Surgical is searching for its next leader. Read MedTech Dive’s roundup for all the details.
-
Abbott gets FDA nod, CE mark for AI-enabled imaging device
The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.
-
Insulet starts study of closed loop insulin delivery system
Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.
-
Stryker cyberattack ‘meaningfully’ impacted Q1
CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year guidance.
-
Meet 7 medtech companies redefining surgical robotics
Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech Dive's series of profiles.
Updated May 1, 2026 -
Aidoc raises $150M to advance clinical AI foundation model
The company wants AI to support all complex diagnostic decisions by 2030 to prevent diagnostic errors and delays.